Professor Andrew Gennery is an Honorary Consultant in Paediatric Immunology and Haematopoietic Stem Cell Transplantation at the Great North Children’s Hospital in Newcastle, Sir James Spence Professor of Child Health, and Professor in Paediatric Immunology and Haematopoietic Stem Cell Transplantation at Newcastle University.
Professor Gennery’s clinical training was in Newcastle and London, and he spent a year of post-doctoral studies working with Anne Durandy and Alain Fischer in the Necker Hospital in Paris.
He was involved in the discovery of Cytidine Deaminase one of the first genes to be discovered involved in class switch recombination and somatic hypermutation.
A member of ESID and EBMT, and previously chair of the ESID/EBMT Inborn Errors working Party and ESID Clinical Working Party, Professor Gennery currently co-chairs the North American CIBMTR Primary Immune Deficiencies, Inborn Errors of Metabolism and other NMMD Working Committee. He is currently paediatric lead on the UKPID Registry Committee.
He has published widely, with over 350 articles on primary immunodeficiency, treatment and outcomes, as well as chapters in major text books.
He has written international guidelines for the treatment of patients with DNA repair disorders and CD40 ligand deficiency, conditioning guidelines for transplant of patients with primary immunodeficiency, and on the use of extracorporeal photopheresis for the treatment of acute graft versus host disease.
He is PID sub-section editor of the Orphanet Journal of Rare Diseases, Associate Editor for Frontiers in Immunology and Editorial Board member of Journal of Clinical Immunology.
Professor Gennery is working with Public Health England to introduce Newborn Screening for Severe Combined Immunodeficiencies.
He is also the Human Tissue Authority Designated Individual overseeing tissue for therapeutic use within Newcastle.
Research
Professor Gennery’s research interests include immunoreconstitution following haematopoietic stem cell transplant for primary immunodeficiency, long-term outcomes of transplantation for primary immunodeficiency, management of complications post-HSCT, DNA repair disorders and their appropriate treatment, and induction of immune tolerance.
He has supervised over 25 doctoral students.
You can find out more about Professor Gennery’s research work here:
